Clinical Trial Update: Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial. [Phase 2]

View source ↗

Summary

This document notes the withdrawal of a Phase 2 randomized, placebo-controlled trial evaluating sodium benzoate for attenuated or transient psychosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attenuated Psychosis Syndrome
• Psychosis

Drugs mentioned

• Sodium benzoate (sodium benzoate)

Snippet

Sponsor: Niuvanniemi Hospital | Conditions: Attenuated or Transient Psychosis | Phase 2 | Status: WITHDRAWN